Celltrion develops novel human monoclonal antibodies against influenza virus infection (News-Medical-Net)

Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus. Preliminary tests in laboratory animals indicate that the novel human monoclonal antibodies can be used to prevent disease when given …

See more here:
Celltrion develops novel human monoclonal antibodies against influenza virus infection (News-Medical-Net)